These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 10226856)
41. A model of multivessel coronary artery disease using conscious, chronically instrumented dogs. Hartman JC; Warltier DC J Pharmacol Methods; 1990 Dec; 24(4):297-310. PubMed ID: 2292881 [TBL] [Abstract][Full Text] [Related]
42. Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion. Nichols WW; Nicolini FA; Yang BC; Henson K; Stechmiller JK; Mehta JL Am Heart J; 1994 May; 127(5):1201-11. PubMed ID: 8172047 [TBL] [Abstract][Full Text] [Related]
43. Cardioprotection by ischemic and nonischemic myocardial stress and ischemia in remote organs. Implications for the concept of ischemic preconditioning. Verdouw PD; Gho BC; Koning MM; Schoemaker RG; Duncker DJ Ann N Y Acad Sci; 1996 Sep; 793():27-42. PubMed ID: 8906153 [TBL] [Abstract][Full Text] [Related]
44. Amelioration of ischemia/reperfusion-induced myocardial infarction by the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146). Sasamori J; Aihara K; Yoneyama F; Sato I; Kogi K; Takeo S J Cardiovasc Pharmacol; 2006 Apr; 47(4):614-20. PubMed ID: 16680077 [TBL] [Abstract][Full Text] [Related]
45. Carperitide induces coronary vasodilation and limits infarct size in canine ischemic hearts: role of NO. Asanuma H; Sanada S; Asakura M; Asano Y; Kim J; Shinozaki Y; Mori H; Minamino T; Takashima S; Kitakaze M Hypertens Res; 2014 Aug; 37(8):716-23. PubMed ID: 24694647 [TBL] [Abstract][Full Text] [Related]
46. Comparison of three different A1 adenosine receptor antagonists on infarct size and multiple cycle ischemic preconditioning in anesthetized dogs. Auchampach JA; Jin X; Moore J; Wan TC; Kreckler LM; Ge ZD; Narayanan J; Whalley E; Kiesman W; Ticho B; Smits G; Gross GJ J Pharmacol Exp Ther; 2004 Mar; 308(3):846-56. PubMed ID: 14634049 [TBL] [Abstract][Full Text] [Related]
47. Adenosine type 1 (A1) receptors mediate protection against myocardial infarction produced by chronic, intermittent ingestion of ethanol in dogs. Kehl F; Krolikowski JG; LaDisa JF; Kersten JR; Warltier DC; Pagel PS Int J Cardiol; 2003 Apr; 88(2-3):175-82. PubMed ID: 12714196 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage. Black SC; Driscoll EM; Lucchesi BR J Cardiovasc Pharmacol; 1992 Dec; 20(6):997-1005. PubMed ID: 1282605 [TBL] [Abstract][Full Text] [Related]
49. Presence of a critical coronary artery stenosis does not abolish the protective effect of ischemic preconditioning. Kapadia SJ; Terlato JS; Most AS Circulation; 1997 Mar; 95(5):1286-92. PubMed ID: 9054861 [TBL] [Abstract][Full Text] [Related]
50. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts. Balakumar P; Singh H; Reddy K; Anand-Srivastava MB J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176 [TBL] [Abstract][Full Text] [Related]
51. Effects of pinacidil on myocardial blood flow and infarct size after acute left anterior descending coronary artery occlusion and reperfusion in awake dogs with and without a coexisting left circumflex coronary artery stenosis. Sakamoto S; Liang CS; Stone CK; Hood WB J Cardiovasc Pharmacol; 1989 Nov; 14(5):747-55. PubMed ID: 2481189 [TBL] [Abstract][Full Text] [Related]
53. Relative importance of adenosine A1 and A3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart. Hill RJ; Oleynek JJ; Magee W; Knight DR; Tracey WR J Mol Cell Cardiol; 1998 Mar; 30(3):579-85. PubMed ID: 9515033 [TBL] [Abstract][Full Text] [Related]
54. Effect of E-4031, a class III antiarrhythmic agent, on experimental infarct size in a canine model of myocardial ischemia-reperfusion injury. Holahan MA; Stranieri MT; Stabilito II; Lynch JJ J Cardiovasc Pharmacol; 1992 Jun; 19(6):892-8. PubMed ID: 1376809 [TBL] [Abstract][Full Text] [Related]
55. Effect of adenosine on myocardial 'stunning' in the dog. Sekili S; Jeroudi MO; Tang XL; Zughaib M; Sun JZ; Bolli R Circ Res; 1995 Jan; 76(1):82-94. PubMed ID: 8001281 [TBL] [Abstract][Full Text] [Related]
56. Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo. Kehl F; Pagel PS; Krolikowski JG; Gu W; Toller W; Warltier DC; Kersten JR Anesth Analg; 2002 Nov; 95(5):1162-8, table of contents. PubMed ID: 12401584 [TBL] [Abstract][Full Text] [Related]
57. Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Auchampach JA; Gross GJ Am J Physiol; 1993 May; 264(5 Pt 2):H1327-36. PubMed ID: 8498546 [TBL] [Abstract][Full Text] [Related]
58. Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model. Dai W; Hale SL; Kay GL; Jyrala AJ; Kloner RA Cardiovasc Ther; 2010; 28(1):30-7. PubMed ID: 20074257 [TBL] [Abstract][Full Text] [Related]
59. Protection from AMP 579 can be added to that from either cariporide or ischemic preconditioning in ischemic rabbit heart. Xu Z; Jiao Z; Cohen MV; Downey JM J Cardiovasc Pharmacol; 2002 Oct; 40(4):510-8. PubMed ID: 12352312 [TBL] [Abstract][Full Text] [Related]
60. PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Mizumura T; Auchampach JA; Linden J; Bruns RF; Gross GJ Circ Res; 1996 Sep; 79(3):415-23. PubMed ID: 8781475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]